Michelle Brown

University of North Carolina at Chapel Hill — United States

Arts and Humanities · Social Sciences

41h-index5.6kcitations260works31.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medieval Literature and History(42), Job Satisfaction and Organizational Behavior(35), CAR-T cell therapy research(25), Gastrointestinal Tumor Research and Treatment(20), Synthesis and Biological Evaluation(20)

Publications259 total

Decisions to enrol in employee stock ownership plans: When experiences become a habit
Economic and Industrial Democracy·2025Open Access
Preface
2025
Reviewing, discussing and developing employee performance
Cambridge University Press eBooks·2025
Megatrends and new horizons in performance and reward management
Cambridge University Press eBooks·2025
Employee share ownership
Cambridge University Press eBooks·2025
Index
Cambridge University Press eBooks·2025
References
Cambridge University Press eBooks·2025
Complex HPV-human DNA structures revealed by large-scale DNA analyses in an HPV-cancer derived cell line
2025Open Access
What is known about injury prevention strategies in cricketers? A Scoping Review
Journal of science and medicine in sport·2025Open Access
Think Money Think Male? Examining the Gendered Nature of Bonus Pay Disclosure
Academy of Management Proceedings·2025
What is the Influence of Market Characteristics on the Use of Enabling Workers in FQHCs?
Academy of Management Proceedings·2025
The implementation of indirect calorimetry for patients with acute respiratory failure: Invited commentary on techniques and procedure
Nutrition in Clinical Practice·2025· 1 cited
Development and Validation of a Genomic Knowledge Scale to Advance Informed Decision-Making Research in Genomic Sequencing
UNC Libraries·2025· 2 citedOpen Access
From salary to share ownership? A review of the employee share ownership participation decision
SSRN Electronic Journal·2025Open Access
Patient experience with acute hepatic porphyria before and after long-term givosiran treatment in a qualitative interview study
Molecular Genetics and Metabolism Reports·2024Open Access
282P Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer
Annals of Oncology·2024· 2 citedOpen Access
The phase 3 INTerpath-002 study design: Individualized neoantigen therapy (INT) V940 (mRNA-4157) plus pembrolizumab vs placebo plus pembrolizumab for resected early-stage non–small-cell lung cancer (NSCLC).
Journal of Clinical Oncology·2024· 12 cited
Abstract CT141: mRNA-4157 (V940) individualized neoantigen therapy (INT) + pembrolizumab (pembro) in advanced unresectable HPV- head & neck carcinoma (HNSCC): Clinical & translational analysis
Cancer Research·2024· 4 cited
Abstract CT281: The phase 3 INTerpath-002 study design: Individualized neoantigen therapy (INT) V940 (mRNA-4157) plus pembrolizumab vs placebo plus pembrolizumab for resected early-stage non-small-cell lung cancer (NSCLC)
Cancer Research·2024· 1 cited
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
The Lancet·2024· 604 cited
page 1 of 13Next →

Frequent Co-authors

John Benson(7), Richard Gameson(7), Christina Cregan(4), Carol T. Kulik(4), Anne‐Wil Harzing(3), John S. Heywood(3), Isabel Metz(3), J. Barry Hocking(2), Scott DeGregorio(2), Helen McKee(2), Mark S. Silverberg(2), Jordan Stachelski(2), Emil Chuang(2), Fred Princen(2), Sharat Singh(2), Jeffrey S. Weber(1), Matteo S. Carlino(1), Adnan Khattak(1), Tarek Meniawy(1), George Ansstas(1)